RABEPRAZOLE VIATRIS 20 mg, gastro-resistant tablet 28 tablets, CIP 3400930164907
Active ingredients: RABÉPRAZOLE, Rabeprazole sodium
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant tablet28 tablets, CIP 3400930164907orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RABEPRAZOLE VIATRIS 20 mg, comprimé gastro-résistant
- Pharmaceutical form
- comprimé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 28 comprimé(s) et bouchon à visser
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Jun 2019
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65637767CIP73016490CIP133400930164907Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RABÉPRAZOLEcomprimé | 18,85 mg · un comprimé | FT |
| RABÉPRAZOLE SODIQUEcomprimé | 20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.